Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Review

Utility of combining PIVKA-II and AFP in the surveillance and monitoring of hepatocellular carcinoma in the Asia-Pacific region

Do Young Kim, Bao Nguyen Toan, Chee-Kiat Tan, Irsan Hasan, Lyana Setiawan, Ming-Lung Yu, Namiki Izumi, Nguyen Nguyen Huyen, Pierce Kah-Hoe Chow, Rosmawati Mohamed, Stephen Lam Chan, Tawesak Tanwandee, Teng-Yu Lee, Thi Thanh Nguyen Hai, Tian Yang, Woo-Chang Lee, Henry Lik Yuen Chan

Clin Mol Hepatol. 2023;29(2):277-292. Published online January 30, 2023

DOI: https://doi.org/10.3350/cmh.2022.0212

View: 5781 Download: 465 Web of Science: 12 Crossref: 13

Original Article

Impact of immunosuppressant therapy on early recurrence of hepatocellular carcinoma after liver transplantation

Ju-Yeun Lee, Yul Hee Kim, Nam-Joon Yi, Hyang Sook Kim, Hye Suk Lee, Byung Koo Lee, Hyeyoung Kim, Young Rok Choi, Geun Hong, Kwang-Woong Lee, Kyung-Suk Suh

Clin Mol Hepatol. 2014;20(2):192-203. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.192

View: 9533 Download: 95 Web of Science: 23 Crossref: 22

3

Optimal Cut-off Value of PIVKA-II for Diagnosis of Hepatocellular Carcinoma - Using ROC Curve -

Myong Jin Kim , Kang Woo Bae , Pyoung Ju Seo , In Kook Jeong , Jung Hyuk Kim , Bo Han Lee , Ki Tae Bang , Dong Woo Kim , Il Han Song

Clin Mol Hepatol. 2006;12(3):404-411. Published online January 1, 2000

View: 3596 Download: 73

1

PIVKA-II as a Serological Marker of Hepatocellular Carcinoma

Sook-Hyang Jeong

Clin Mol Hepatol. 2006;12(3):315-317. Published online January 1, 2000

View: 2482 Download: 23

3

Clinical Efficacy of Serum PIVKA-2 in the Diagnosis and Follow up after Treatment of Hepatocellular Carcinoma

Young Joon Yoon, M.D., Kwang-Hyub Han, M.D., Chul Kim, M.D., Chae Yoon Chon, M.D., Young Myoung Moon, M.D., Chang Hoon Han, M.D., Hye Jin Choi, M.D., Yong Soo Kim, M.D., Jae Yong Han, M.D. and Hyon Suk Kim, M.D.†

Clin Mol Hepatol. 2002;8(4):465-471. Published online January 1, 1970

View: 3069 Download: 25

Serum Concentration of Intercellular Adhesion Molecule-1 (ICAM-1) in Patients with Hepatocellular Carcinoma (HCC) with Low AFP

Hyun Ju Park, Joung Il Lee, Seok Ho Dong, Hyo Jong Kim, Byoung Ho Kim, Young Woon Chang and Rin Chang

Clin Mol Hepatol. 1998;4(4):346-357. Published online January 1, 2000

View: 2285 Download: 14

1 |

Viewed By 5133	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 4995	MAFLD: How is it different from NAFLD?
Viewed By 4893	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3598	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3570	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 67	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 51	MAFLD: How is it different from NAFLD?

Search